Black Hawk Acquisition Corp (BKHA) stock
BKHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends November 30Also trades as BKHAR, BKHAU
$8.65+1.45 (+20.14%)
Close on Nov 17, 2026Market cap $35.93MP/E –Yield –
Black Hawk Acquisition r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Black Hawk Acquisition
Black Hawk Acquisition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?